In a follow-up editorial to the New England Journal of Medicine Study, David Standaert MD PhD from the University of Alabama commented that, Although a variety of physiological effects are observed in response to GLP-1 receptor activation, a consistent finding is reduced inflammation in the brain, a process that is central to the pathophysiology of Parkinsons disease. Have there been other trials of GLP-1 drugs in Parkinsons disease besides Lixisenatide
You can use MeAgain with or instead of Noom If you already use Noom, the useful habits transfer naturally: logging food, tracking water, watching protein, weighing in, learning what affects appetite, and paying attention to consistency
It covers the highest doses used in GLP-1 therapy
2012;7:e35054
A recent study indicates that CPT1C might be induced in the MCF-7 breast cancer cell line by the indirect action of activated 5 AMP-activated protein kinase (AMPK) 48
More is not automatically better